UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Details {2}
Sales, net	$ 9,953	$ 10,400	$ 19,663	$ 21,740
Cost of goods sold	4,358	4,147	8,530	8,722
Gross profit	5,595	6,253	11,133	13,018
Operating expense
Selling, general and administrative	2,264	2,560	4,495	5,176
Research & development	135	255	289	521
Total operating expenses	2,399	2,815	4,784	5,697
Operating income	3,196	3,438	6,349	7,321
Other income	640	773	1,345	1,689
Income before provision for income taxes	3,836	4,211	7,694	9,010
Provision for income taxes	788	758	1,605	1,601
Net income	$ 3,048	$ 3,453	$ 6,089	$ 7,409
Earnings per share, basic	$ 0.94	$ 0.98	$ 1.86	$ 2.07
Earnings per common share (diluted)	$ 0.94	$ 0.98	$ 1.86	$ 2.07
Shares outstanding - basic	3,246	3,532	3,278	3,579
Shares outstanding - diluted	3,246	3,532	3,278	3,579
Foreign currency translation net of taxes of $0 in all periods	$ 1,828	$ (33)	$ 2,546	$ (664)
Total comprehensive income	$ 4,876	$ 3,420	$ 8,635	$ 6,745